1. Home
  2. JBLU vs NVAX Comparison

JBLU vs NVAX Comparison

Compare JBLU & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JetBlue Airways Corporation

JBLU

JetBlue Airways Corporation

N/A

Current Price

$2.83

Market Cap

2.1B

ML Signal

N/A

Logo Novavax Inc.

NVAX

Novavax Inc.

N/A

Current Price

$10.01

Market Cap

2.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
JBLU
NVAX
Founded
1998
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Air Freight/Delivery Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.1B
IPO Year
2002
1996

Fundamental Metrics

Financial Performance
Metric
JBLU
NVAX
Price
$2.83
$10.01
Analyst Decision
Hold
Buy
Analyst Count
17
9
Target Price
$4.10
★ $14.44
AVG Volume (30 Days)
★ 29.7M
8.4M
Earning Date
10-26-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
27.83
★ 309.76
EPS
N/A
★ N/A
Revenue
★ $9,062,000,000.00
$1,123,479,000.00
Revenue This Year
$16.17
N/A
Revenue Next Year
$9.03
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 64.69
52 Week Low
$2.16
$6.20
52 Week High
$6.62
$13.39

Technical Indicators

Market Signals
Indicator
JBLU
NVAX
Relative Strength Index (RSI) 36.08 44.30
Support Level N/A $7.93
Resistance Level $6.31 $10.48
Average True Range (ATR) 0.28 0.88
MACD 0.03 -0.23
Stochastic Oscillator 44.30 24.37

Price Performance

Historical Comparison
JBLU
NVAX

About JBLU JetBlue Airways Corporation

JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It served approximately 100 destinations in the United States, the Caribbean and Latin America, Canada, and England. The company currently operates Airbus A321, Airbus A320, Airbus A321neo, and Embraer E190 aircraft types. The company has one operating segment, Air Transportation Services, which provides services in the United States, the Caribbean, Latin America, Canada, and Europe. The majority of revenue is generated from the Domestic & Canada segment.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: